Background: Leucine-rich repeat-containing protein-25 (LRRC25) can degrade the ISG15 gene in virus-infected cells and prevent overactivation of the type Ⅰ IFN pathway. However, the role of LRRC25 in bacterial infection is still unclear. In this pursuit, the present study aimed to explore the regulatory role and mechanism of LRRC25 in microglia infected with Mycobacterium tuberculosis in a mouse model. Methods: Q-PCR, WB, and cell immunofluorescence were employed to observe the change in LRRC25 in BV2 cells infected by H37Rv. Additionally, siRNA was designed to target the LRRC25 to inhibit its expression in BV2 cells. Flow cytometry and laser confocal imaging were used to observe the infection of BV2 cells after LRRC25 silencing. Q-PCR and ELISA were used to determine the changes in IFN-γ and ISG15 in the culture supernatant of each group. Results: Following H37Rv infection, it was observed that the expression of LRRC25 was upregulated. Upon silencing LRRC25, the proportion of BV2 cells infected by H37Rv decreased significantly. ELISA analysis showed that IFN-γ and ISG15 levels in cell culture supernatant decreased after H37Rv infection, while they significantly increased after LRRC25 silencing. Conclusions: This study provides evidence that LRRC25 is the key negative regulator of microglial anti-Mtb immunity. It exerts its function by degrading free ISG15 and inhibiting the secretion of IFN-γ, thereby improving the anti-Mtb immunity of BV2 cells.
Objective: This study aims to explore potential biological biomarkers for brucellosis by integrating transcriptomic profiling and bioinformatics-driven approaches. Methods: Differentially expressed genes (DEGs) associated with acute and chronic brucellosis were identified using transcriptomic data from the Gene Expression Omnibus (GEO). Functional annotation and pathway enrichment analysis of DEGs were performed using Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG). Weighted Gene Co-expression Network Analysis (WGCNA) was applied to construct gene co-expression modules, followed by screening of modules significantly correlated with disease phenotypes. Notably, a multi-model machine learning framework was employed for systematic screening, cross-validation, and validation of diagnostically relevant biomarkers—ensuring robustness and generalizability of the findings. Results: A total of 103 brucellosis patients and 46 healthy controls with whole blood transcriptomic profiles were included. Comparative analysis identified 264 DEGs, which were predominantly enriched in mitotic nuclear division, chromosome segregation, nucleocytoplasmic transport, cell cycle regulation, and cytokine-cytokine receptor interaction pathways—providing novel insights into the molecular pathogenesis of brucellosis. Immune infiltration profiling revealed that brucellosis progression was positively correlated with CD8+ T cells, follicular helper T cells, and resting NK cells—highlighting previously underappreciated immune regulatory mechanisms. Two co-expression modules were significantly associated with brucellosis clinical traits through WGCNA. Cross-validation using machine learning algorithms (LASSO, SVM, random forest) prioritized six overlapping hub genes: RTP5, KIF19, CDKN2A, RCAN2, GLB1L3, and IL12RB2. Receiver Operating Characteristic (ROC) curve analysis demonstrated robust diagnostic performance, supporting their potential as combinatorial biomarkers for brucellosis detection. Discussion: These novel hub genes are closely implicated in inflammatory responses, neutrophil regulation, and B cell receptor signaling pathways—key processes underlying brucellosis pathogenesis that have not been previously targeted for diagnostic biomarker development. This work not only enhances our understanding of brucellosis biology but also lays a critical foundation for the development of non-invasive, accurate diagnostic tools and targeted therapeutic strategies—filling a significant gap in current brucellosis management.